Pomerantz Law Firm Investigates Claims on Behalf of Investors of BrightPoint, Inc

NEW YORK--(BUSINESS WIRE)--Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of BrightPoint, Inc. (“BrightPoint” or the “Company”) (NASDAQ: CELL) (ISIN: US109473405) concerning the proposed acquisition of BrightPoint by Ingram Micro Inc. in a cash transaction valued at approximately $840 million. The investigation concerns whether the BrightPoint directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholde a styl